Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous IL-1 receptor antagonist in acute ischaemic stroke
ISRCTN74236229Phase 2Completed
- Sponsor
- Salford Royal NHS Foundation Trust
- Start
- Nov 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial in ischemic stroke comparing Kineret with Placebo (2 arms). Primary endpoint: Level of interleukin-6. Started Nov 2013; status: completed.
02
Drugs
anakinra
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ISRCTN74236229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74236229.